Effects of the cannabinoid receptor agonist, HU 210, on ingestive behaviour and body weight of rats

By Giuliani D.   Ottani A.   Ferrari F.  

European Journal of Pharmacology, Vol. 391, Iss. 3, 2000-03 ,pp. : 275-279

Elsevier

Access to resources Recommend Favorite

Rat Cognitive Functions During and After Treatment with the Cannabinoid Agonist, HU 210

By Ottani A.   Giuliani D.   Ferrari F.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 6, 2000-06 ,pp. : 243-246

Pharmaceutical Press

Access to resources Recommend Favorite

The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats

By Jarbe T.U.C.   DiPatrizio N.V.   Li C.   Makriyannis A.  

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 4, 2003-07 ,pp. : 809-821

Elsevier

Access to resources Recommend Favorite

Characterization of the acute endocrine actions of (-)-11-hydroxy- 8 -tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats

By Martn-Calderon J.L.   Munoz R.M.   Villanua M.A.   del Arco I.   Moreno J.L.   de Fonseca F.R.   Navarro M.  

European Journal of Pharmacology, Vol. 344, Iss. 1, 1998-02 ,pp. : 77-86

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist

By De Vry J.   Rudiger Jentzsch K.  

European Journal of Pharmacology, Vol. 457, Iss. 2, 2002-12 ,pp. : 147-152

Elsevier

Access to resources Recommend Favorite